These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 22425748)
21. Inhibition of NAD+-dependent histone deacetylases (sirtuins) causes growth arrest and activates both apoptosis and autophagy in the pathogenic protozoan Trypanosoma cruzi. Veiga-Santos P; Reignault LC; Huber K; Bracher F; De Souza W; De Carvalho TM Parasitology; 2014 May; 141(6):814-25. PubMed ID: 24670415 [TBL] [Abstract][Full Text] [Related]
22. Effect of L-leucine methyl ester on growth and ultrastructure of Trypanosoma cruzi. Adade CM; Figueiredo RC; De Castro SL; Soares MJ Acta Trop; 2007 Jan; 101(1):69-79. PubMed ID: 17250794 [TBL] [Abstract][Full Text] [Related]
23. Selective activity of polyene macrolides produced by genetically modified Streptomyces on Trypanosoma cruzi. Rolón M; Seco EM; Vega C; Nogal JJ; Escario JA; Gómez-Barrio A; Malpartida F Int J Antimicrob Agents; 2006 Aug; 28(2):104-9. PubMed ID: 16844353 [TBL] [Abstract][Full Text] [Related]
24. Trypanosoma cruzi: in vitro activity of Epoxy-alpha-Lap, a derivative of alpha-lapachone, on trypomastigote and amastigote forms. Bourguignon SC; Castro HC; Santos DO; Alves CR; Ferreira VF; Gama IL; Silva FC; Seguins WS; Pinho RT Exp Parasitol; 2009 Jun; 122(2):91-6. PubMed ID: 19285074 [TBL] [Abstract][Full Text] [Related]
25. The efficacy of novel arylimidamides against Trypanosoma cruzi in vitro. DA Silva CF; Daliry A; DA Silva PB; Akay S; Banerjee M; Farahat AA; Fisher MK; Hu L; Kumar A; Liu Z; Stephens CE; Boykin DW; Correia Soeiro MD Parasitology; 2011 Dec; 138(14):1863-9. PubMed ID: 21902869 [TBL] [Abstract][Full Text] [Related]
26. 2H-benzimidazole 1,3-dioxide derivatives: a new family of water-soluble anti-trypanosomatid agents. Boiani M; Boiani L; Denicola A; Torres de Ortiz S; Serna E; Vera de Bilbao N; Sanabria L; Yaluff G; Nakayama H; Rojas de Arias A; Vega C; Rolan M; Gómez-Barrio A; Cerecetto H; Gonzalez M J Med Chem; 2006 Jun; 49(11):3215-24. PubMed ID: 16722639 [TBL] [Abstract][Full Text] [Related]
27. Anti-proliferative effect of the essential oil of Cymbopogon citratus (DC) Stapf (lemongrass) on intracellular amastigotes, bloodstream trypomastigotes and culture epimastigotes of Trypanosoma cruzi (Protozoa: Kinetoplastida). Santoro GF; Cardoso MG; Guimarães LG; Freire JM; Soares MJ Parasitology; 2007 Oct; 134(Pt 11):1649-56. PubMed ID: 17686189 [TBL] [Abstract][Full Text] [Related]
28. Biological activity of the azlactone derivative EPA-35 against Trypanosoma cruzi. de Azeredo CM; Ávila EP; Pinheiro DL; Amarante GW; Soares MJ FEMS Microbiol Lett; 2017 Feb; 364(4):. PubMed ID: 28130370 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi. Manarin R; Lamas MC; Bottasso E; Serra E; Revelli S; Salomón CJ Parasitol Int; 2013 Feb; 62(1):79-81. PubMed ID: 22975280 [TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents. dos Santos Filho JM; Leite AC; de Oliveira BG; Moreira DR; Lima MS; Soares MB; Leite LF Bioorg Med Chem; 2009 Sep; 17(18):6682-91. PubMed ID: 19683450 [TBL] [Abstract][Full Text] [Related]
31. In vitro trypanocidal activities of a novel series of N, N-dimethyl-2-propen-1-amine derivative. De Conti R; Rita RM; de Souza EM; Melo PS; Haun M; De Castro SL; Durán N Microbios; 1996; 85(343):83-7. PubMed ID: 8643034 [TBL] [Abstract][Full Text] [Related]
32. Ruthenium complexes endowed with potent anti-Trypanosoma cruzi activity: Synthesis, biological characterization and structure-activity relationships. Donnici CL; Araújo MH; Oliveira HS; Moreira DR; Pereira VR; de Assis Souza M; de Castro MC; Leite AC Bioorg Med Chem; 2009 Jul; 17(14):5038-43. PubMed ID: 19539479 [TBL] [Abstract][Full Text] [Related]
33. Trypanocidal effect of the benzyl ester of N-propyl oxamate: a bi-potential prodrug for the treatment of experimental Chagas disease. Wong-Baeza C; Nogueda-Torres B; Serna M; Meza-Toledo S; Baeza I; Wong C BMC Pharmacol Toxicol; 2015 Apr; 16():10. PubMed ID: 25896924 [TBL] [Abstract][Full Text] [Related]
34. Activity of "reversed" diamidines against Trypanosoma cruzi "in vitro". Silva CF; Batista MM; Mota RA; de Souza EM; Stephens CE; Som P; Boykin DW; Soeiro Mde N Biochem Pharmacol; 2007 Jun; 73(12):1939-46. PubMed ID: 17462605 [TBL] [Abstract][Full Text] [Related]
35. Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease. Guedes PM; Oliveira FS; Gutierrez FR; da Silva GK; Rodrigues GJ; Bendhack LM; Franco DW; Do Valle Matta MA; Zamboni DS; da Silva RS; Silva JS Br J Pharmacol; 2010 May; 160(2):270-82. PubMed ID: 20128813 [TBL] [Abstract][Full Text] [Related]
36. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target. Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250 [TBL] [Abstract][Full Text] [Related]
37. Second generation of 5-ethenylbenzofuroxan derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and structure-activity relationships. Porcal W; Hernández P; Aguirre G; Boiani L; Boiani M; Merlino A; Ferreira A; Maio RD; Castro A; González M; Cerecetto H Bioorg Med Chem; 2007 Apr; 15(7):2768-81. PubMed ID: 17287123 [TBL] [Abstract][Full Text] [Related]
38. Trypanocidal and cytotoxic activities of essential oils from medicinal plants of Northeast of Brazil. Borges AR; Aires JR; Higino TM; de Medeiros Md; Citó AM; Lopes JA; de Figueiredo RC Exp Parasitol; 2012 Oct; 132(2):123-8. PubMed ID: 22771867 [TBL] [Abstract][Full Text] [Related]
39. Decoding the anti-Trypanosoma cruzi action of HIV peptidase inhibitors using epimastigotes as a model. Sangenito LS; Menna-Barreto RF; D Avila-Levy CM; Santos AL; Branquinha MH PLoS One; 2014; 9(12):e113957. PubMed ID: 25464510 [TBL] [Abstract][Full Text] [Related]
40. Development of parenteral formulations and evaluation of the biological activity of the trypanocide drug benznidazole. Lamas MC; Villaggi L; Nocito I; Bassani G; Leonardi D; Pascutti F; Serra E; Salomón CJ Int J Pharm; 2006 Jan; 307(2):239-43. PubMed ID: 16293378 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]